Clinical trials during epidemics

The Lancet

Volumn 389, Issue 10088, 2017, Pages 2455-2457

  Keusch, Gerald T ^a   McAdam, Keith P W J ^b  

^a BOSTON UNIVERSITY   (United States)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; EBOLA VACCINE;

CLINICAL RESEARCH; CLINICAL TRIAL (TOPIC); CONFLICT OF INTEREST; CONSENSUS; DRUG EFFICACY; DRUG SAFETY; EBOLA HEMORRHAGIC FEVER; EPIDEMIC; HEALTH CARE SYSTEM; HUMAN; INFECTION RISK; NONHUMAN; NOTE; PRIORITY JOURNAL; PUBLIC HEALTH; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESEARCH ETHICS; TREATMENT PLANNING; WORLD HEALTH ORGANIZATION; GUINEA; PROFESSIONAL-PATIENT RELATIONSHIP; TIME FACTOR;

EPIDEMICS; GUINEA; HEMORRHAGIC FEVER, EBOLA; HUMANS; PROFESSIONAL-PATIENT RELATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TIME FACTORS;

EID: 85032507806     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(17)31602-1     Document Type: Note

References (9)

1. US National Academies of Sciences, Engineering and Medicine. Committee on Clinical Trials During the 2014–2015 Ebola Outbreak. Integrating clinical research into epidemic response: the Ebola experience, 2017, The National Academies Press, Washington, DC https://www.nap.edu/catalog/24739/integrating-clinical-research-into-epidemic-response-the-ebola-experience (accessed June 12, 2017).
2. WHO. International Health Regulations (2005), Third edition, 2016, World Health Organization, Geneva http://apps.who.int/iris/bitstream/10665/246107/1/9789241580496-eng.pdf?ua=1 (accessed June 12, 2017).
3. WHO Regional Office for Africa. Ebola haemorrhagic fever in Guinea (situation as of 25 March 2014). http://www.afro.who.int/en/disease-outbreaks/outbreak-news/4065-ebola-virus-disease-in-guinea-25-march-2014.html, 2014 (accessed June 12, 2017).
4. WHO. Statement on the 1st meeting of the IHR Emergency Committee on the 2014 Ebola outbreak in West Africa. http://www.who.int/mediacentre/news/statements/2014/ebola-20140808/en/, 2014 (accessed June 12, 2017).
5. Lang, T, Ebola: embed research in outbreak response. Nature 524 (2015), 29–31.
6. Doe-Anderson, J, Baseler, B, Driscoll, P, et al. 2016. Beating the odds: successful establishment of a phase II/III clinical research trial in resource-poor Liberia during the largest-ever Ebola outbreak. Contemp Clin Trials Commun 4 (2016), 68–73.
7. Wilkinson, S, Using media and communication to respond to public health emergencies: lessons learned from Ebola, 2016, BBC Media Action, London http://downloads.bbc.co.uk/mediaaction/pdf/practicebriefings/ebola-lessons-learned.pdf (accessed June 12, 2017).
8. Adebamowo, O, Bah-Sow, O, Binka, F, et al. Randomised controlled trials for Ebola: practical and ethical issues. Lancet 384 (2014), 1423–1424.
9. Kennedy, SB, Neaton, JD, Lane, HC, et al. Implementation of an Ebola virus disease vaccine clinical trial during the Ebola epidemic in Liberia: design, procedures, and challenges. Clin Trials 13 (2016), 49–56.